We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

It takes two

27 November 2017 By Lauren Silva Laughlin

The activist joined another angry investor to stop oil driller SandRidge’s $746 mln acquisition of rival Bonanza. SandRidge adopted a poison pill to block him. It is an egregious example of oil companies chasing size at shareholders’ expense. On principle, it’s worth the battle.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)